Kennedy Capital Management, Inc. 4 D Molecular Therapeutics, Inc. Transaction History
Kennedy Capital Management, Inc.
- $4.27 Billion
- Q3 2024
A detailed history of Kennedy Capital Management, Inc. transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 351,653 shares of FDMT stock, worth $2.82 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
351,653
Previous 176,765
98.94%
Holding current value
$2.82 Million
Previous $3.71 Million
2.45%
% of portfolio
0.09%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding FDMT
# of Institutions
143Shares Held
57.6MCall Options Held
137KPut Options Held
51.8K-
Bvf Inc San Francisco, CA7.38MShares$59.2 Million2.54% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.1MShares$40.9 Million0.77% of portfolio
-
Black Rock Inc. New York, NY4.9MShares$39.3 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.4MShares$35.3 Million4.93% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.1MShares$32.9 Million1.63% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $260M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...